Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mustafa Diken

Showing results (41-50 of 95) with videos related to

Pageof 10
Sort By:
Human Gene Therapy|September 8, 2017
Improvement of In Vivo Expression of Genes Delivered by Self-Amplifying RNA Using Vaccinia Virus Immune Evasion ProteinsTim Beissert, Lars Koste, Mario Perkovic, et al.
EJNMMI Research|August 17, 2018
In vivo imaging of the immune response upon systemic RNA cancer vaccination by FDG-PETStefanie Pektor, Lina Hilscher, Kerstin C Walzer, et al.
Human Vaccines & Immunotherapeutics|December 9, 2014
CIMT 2014: Next waves in cancer immunotherapy--report on the 12th annual meeting of the Association for Cancer Immunotherapy: May 6–8 2014, Mainz, GermanyMustafa Diken, Sebastian Boegel, Christian Grunwitz, et al.
BMC Developmental Biology|September 7, 2010
Tetracycline-controlled transgene activation using the ROSA26-iM2-GFP knock-in mouse strain permits GFP monitoring of DOX-regulated transgene-expressionSimone Wörtge, Leonid Eshkind, Nina Cabezas-Wallscheid, et al.
Human Vaccines & Immunotherapeutics|July 21, 2016
CIMT 2016: Mechanisms of efficacy in cancer immunotherapy - Report on the 14th Annual Meeting of the Association for Cancer Immunotherapy May 10-12 2016, Mainz, GermanyLena M Kranz, Matthias Birtel, Lina Hilscher, et al.
Genome Medicine|December 25, 2012
HLA typing from RNA-Seq sequence readsSebastian Boegel, Martin Löwer, Michael Schäfer, et al.
Oncoimmunology|May 31, 2019
Intravenous delivery of the toll-like receptor 7 agonist SC1 confers tumor control by inducing a CD8+ T cell responseFulvia Vascotto, Jutta Petschenka, Kerstin C Walzer, et al.
Biomacromolecules|June 6, 2014
Enhanced in vivo targeting of murine nonparenchymal liver cells with monophosphoryl lipid A functionalized microcapsulesAnette Pietrzak-Nguyen, Michael Fichter, Marvin Dedters, et al.
Pharmaceutics|August 26, 2023
Polysarcosine-Functionalized mRNA Lipid Nanoparticles Tailored for ImmunotherapyChristoph Wilhelmy, Isabell Sofia Keil, Lukas Uebbing, et al.
Cancer Immunology, Immunotherapy : CII|December 31, 2021
Local radiotherapy and E7 RNA-LPX vaccination show enhanced therapeutic efficacy in preclinical models of HPV16<sup>+</sup> cancerNadja Salomon, Abderaouf Selmi, Christian Grunwitz, et al.
Pageof 10

Showing results (41-50 of 95) with videos related to

Sort By:
Pageof 10
Human Gene Therapy|September 8, 2017
Improvement of In Vivo Expression of Genes Delivered by Self-Amplifying RNA Using Vaccinia Virus Immune Evasion ProteinsTim Beissert, Lars Koste, Mario Perkovic, et al.
EJNMMI Research|August 17, 2018
In vivo imaging of the immune response upon systemic RNA cancer vaccination by FDG-PETStefanie Pektor, Lina Hilscher, Kerstin C Walzer, et al.
Human Vaccines & Immunotherapeutics|December 9, 2014
CIMT 2014: Next waves in cancer immunotherapy--report on the 12th annual meeting of the Association for Cancer Immunotherapy: May 6–8 2014, Mainz, GermanyMustafa Diken, Sebastian Boegel, Christian Grunwitz, et al.
BMC Developmental Biology|September 7, 2010
Tetracycline-controlled transgene activation using the ROSA26-iM2-GFP knock-in mouse strain permits GFP monitoring of DOX-regulated transgene-expressionSimone Wörtge, Leonid Eshkind, Nina Cabezas-Wallscheid, et al.
Human Vaccines & Immunotherapeutics|July 21, 2016
CIMT 2016: Mechanisms of efficacy in cancer immunotherapy - Report on the 14th Annual Meeting of the Association for Cancer Immunotherapy May 10-12 2016, Mainz, GermanyLena M Kranz, Matthias Birtel, Lina Hilscher, et al.
Genome Medicine|December 25, 2012
HLA typing from RNA-Seq sequence readsSebastian Boegel, Martin Löwer, Michael Schäfer, et al.
Oncoimmunology|May 31, 2019
Intravenous delivery of the toll-like receptor 7 agonist SC1 confers tumor control by inducing a CD8+ T cell responseFulvia Vascotto, Jutta Petschenka, Kerstin C Walzer, et al.
Biomacromolecules|June 6, 2014
Enhanced in vivo targeting of murine nonparenchymal liver cells with monophosphoryl lipid A functionalized microcapsulesAnette Pietrzak-Nguyen, Michael Fichter, Marvin Dedters, et al.
Pharmaceutics|August 26, 2023
Polysarcosine-Functionalized mRNA Lipid Nanoparticles Tailored for ImmunotherapyChristoph Wilhelmy, Isabell Sofia Keil, Lukas Uebbing, et al.
Cancer Immunology, Immunotherapy : CII|December 31, 2021
Local radiotherapy and E7 RNA-LPX vaccination show enhanced therapeutic efficacy in preclinical models of HPV16<sup>+</sup> cancerNadja Salomon, Abderaouf Selmi, Christian Grunwitz, et al.
Pageof 10